Archive

Tag: Atrial Fibrillation

AFib: Wait-and-See or Early Cardioversion to Obtain Normal Sinus Rhythm?

Background: Atrial fibrillation (AF) is a common cardiac dysrhythmia encountered in the emergency department (ED), affecting 2.7 million – 6.1 million Americans annually. Hospitalizations with AF as the primary diagnosis total >467,000 annually. AF is associated with a 5-fold increased risk ...

Read More
Cardiovascular

LOMAGHI Trial: Magnesium Sulfate for Rapid Atrial Fibrillation?

Background: Currently, several medications are recommended for the management of atrial fibrillation with rapid ventricular response in the emergency department including calcium channel blockers, beta blockers and digoxin (the optimal choice is still up for debate). Magnesium sulfate may play a role ...

Read More
Cardiovascular

The BEST AF Trial: What is the Optimal Energy Selection for Cardioversion in Patients with Afib?

Background:There are two trains of thought in using transthoracic direct current cardioversion (DCCV) when it comes to converting atrial fibrillation.  The first is an escalating energy approach which allows cardioversion to occur at the lowest energy for each individual patient ...

Read More
Cardiovascular

Is Amiodarone Dead?

Background: Amiodarone is a class III antidysrhythmic first released for human use in 1962. As with other drugs in this class, amiodarone acts by blocking potassium channels thus prolonging the action potential. This, in turn, leads to a lengthening of depolarization ...

Read More
CardiovascularResuscitation

Outcomes After Aggressive Management of Recent-Onset Atrial Fibrillation in the ED

Background: Atrial fibrillation (AF) is one of the most common dysrhythmias encountered in the ED. The management of recent-onset AF and atrial flutter (AFl) in the ED continues to be debated. The discussion centers on whether patients with recent-onset AF ...

Read More
Cardiovascular

Sponsored